Human equilibrative nucleoside transporter 1 as independent factor of good prognosis for resectable pancreatic cancer patients treated with gemcitabine-based regimen | |
Di Y., Yu X., Li J., Yang F., Li H., Hao S., Ouyang Q., Fu D., Jin C. | |
刊名 | Pancreatology
![]() |
2016 | |
ISSN号 | 1424-3911 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4287740 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Di Y., Yu X., Li J., Yang F., Li H., Hao S., Ouyang Q., Fu D., Jin C.. Human equilibrative nucleoside transporter 1 as independent factor of good prognosis for resectable pancreatic cancer patients treated with gemcitabine-based regimen[J]. Pancreatology,2016. |
APA | Di Y., Yu X., Li J., Yang F., Li H., Hao S., Ouyang Q., Fu D., Jin C..(2016).Human equilibrative nucleoside transporter 1 as independent factor of good prognosis for resectable pancreatic cancer patients treated with gemcitabine-based regimen.Pancreatology. |
MLA | Di Y., Yu X., Li J., Yang F., Li H., Hao S., Ouyang Q., Fu D., Jin C.."Human equilibrative nucleoside transporter 1 as independent factor of good prognosis for resectable pancreatic cancer patients treated with gemcitabine-based regimen".Pancreatology (2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论